HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $802,275 | -30.2% | 24,482 | -25.0% | 0.00% | 0.0% |
| Q2 2023 | $1,148,919 | +60.3% | 32,649 | +48.8% | 0.00% | 0.0% |
| Q1 2023 | $716,537 | -54.1% | 21,946 | -22.6% | 0.00% | 0.0% |
| Q4 2022 | $1,562,691 | +34.6% | 28,361 | +8.1% | 0.00% | 0.0% |
| Q3 2022 | $1,161,000 | +17.4% | 26,235 | +29.4% | 0.00% | 0.0% |
| Q2 2022 | $989,000 | -19.3% | 20,270 | -19.5% | 0.00% | 0.0% |
| Q1 2022 | $1,225,000 | +36.0% | 25,172 | +19.1% | 0.00% | – |
| Q4 2021 | $901,000 | +704.5% | 21,142 | +621.3% | 0.00% | – |
| Q3 2021 | $112,000 | +83.6% | 2,931 | +36.6% | 0.00% | – |
| Q2 2021 | $61,000 | +103.3% | 2,146 | +139.8% | 0.00% | – |
| Q1 2021 | $30,000 | -37.5% | 895 | -32.1% | 0.00% | – |
| Q4 2020 | $48,000 | – | 1,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |